44 research outputs found
Maximum Cliques in Protein Structure Comparison
Computing the similarity between two protein structures is a crucial task in
molecular biology, and has been extensively investigated. Many protein
structure comparison methods can be modeled as maximum clique problems in
specific k-partite graphs, referred here as alignment graphs. In this paper, we
propose a new protein structure comparison method based on internal distances
(DAST) which is posed as a maximum clique problem in an alignment graph. We
also design an algorithm (ACF) for solving such maximum clique problems. ACF is
first applied in the context of VAST, a software largely used in the National
Center for Biotechnology Information, and then in the context of DAST. The
obtained results on real protein alignment instances show that our algorithm is
more than 37000 times faster than the original VAST clique solver which is
based on Bron & Kerbosch algorithm. We furthermore compare ACF with one of the
fastest clique finder, recently conceived by Ostergard. On a popular benchmark
(the Skolnick set) we observe that ACF is about 20 times faster in average than
the Ostergard's algorithm
Singularly Perturbed Monotone Systems and an Application to Double Phosphorylation Cycles
The theory of monotone dynamical systems has been found very useful in the
modeling of some gene, protein, and signaling networks. In monotone systems,
every net feedback loop is positive. On the other hand, negative feedback loops
are important features of many systems, since they are required for adaptation
and precision. This paper shows that, provided that these negative loops act at
a comparatively fast time scale, the main dynamical property of (strongly)
monotone systems, convergence to steady states, is still valid. An application
is worked out to a double-phosphorylation ``futile cycle'' motif which plays a
central role in eukaryotic cell signaling.Comment: 21 pages, 3 figures, corrected typos, references remove
Impact of Competition on Quality of Service in Demand Responsive Transit
Demand responsive transportation has the potential to provide efficient public door-to-door transport with a high quality. In currently implemented systems in the Netherlands, however, we observe a decrease in the quality of service (QoS), expressed in longer travel times for the customers. Currently, generally one transport company is responsible for transporting all customers located in a specified geographic zone. In general it is known that when multiple companies compete on costs, the price for customers decreases. In this paper, we investigate whether a similar result can be achieved when competing on quality instead. To arrive at some first conclusions, we set up a multiagent environment to simulate the assignment of rides to companies through an auction on QoS, and the insertion of allocated rides in the companies' schedules using online optimization. Our results reveal that this set-up improves the quality of the service offered to the customers at moderately higher costs.Software Computer TechnologyElectrical Engineering, Mathematics and Computer Scienc
Depression history modulates effects of subthalamic nucleus topography on neuropsychological outcomes of deep brain stimulation for Parkinson’s disease
Patients with psychiatric symptoms, such as depression, anxiety, and visual hallucinations, may be at increased risk for adverse effects following deep brain stimulation of the subthalamic nucleus for Parkinson’s disease, but there have been relatively few studies of associations between locations of chronic stimulation and neuropsychological outcomes. We sought to determine whether psychiatric history modulates associations between stimulation location within the subthalamic nucleus and postoperative affective and cognitive changes. We retrospectively identified 42 patients with Parkinson’s disease who received bilateral subthalamic nucleus deep brain stimulation and who completed both pre- and postoperative neuropsychological testing. Active stimulation contacts were localized in MNI space using Lead-DBS software. Linear discriminant analysis identified vectors maximizing variance in postoperative neuropsychological changes, and Pearson’s correlations were used to assess for linear relationships. Stimulation location was associated with postoperative change for only 3 of the 18 neuropsychological measures. Variation along the superioinferior (z) axis was most influential. Constraining the analysis to patients with a history of depression revealed 10 measures significantly associated with active contact location, primarily related to location along the anterioposterior (y) axis and with worse outcomes associated with more anterior stimulation. Analysis of patients with a history of anxiety revealed 5 measures with location-associated changes without a predominant axis. History of visual hallucinations was not associated with significant findings. Our results suggest that a history of depression may influence the relationship between active contact location and neuropsychological outcomes following subthalamic nucleus deep brain stimulation. These patients may be more sensitive to off-target (nonmotor) stimulation. © 2022, The Author(s).Open access journalThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]
Recommended from our members
Association of Molecular Senescence Markers in Late-Life Depression with Clinical Characteristics and Treatment Outcome
Importance: Many older adults with depression do not experience remission with antidepressant treatment, and markers of cellular senescence in late-life depression (LLD) are associated with greater severity of depression, greater executive dysfunction, and higher medical illness burden. Since these clinical characteristics are associated with remission in LLD, molecular and cellular senescence abnormalities could be a possible biological mechanism underlying poor treatment response in this population. Objective: To examine whether the senescence-associated secretory phenotype (SASP) index was associated with the likelihood of remission from a depressive episode in older adults. Design, Setting, and Participants: A nonrandomized, open-label clinical trial was conducted between August 2009 and August 2014 in Pittsburgh, Pennsylvania; St Louis, Missouri; and Toronto, Ontario, Canada, with older adults in a current major depressive episode according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, Text Revision) diagnostic criteria. Data from biomarker analyses were reported according to the clinical trial archived plasma samples run in March 2021. Data were analyzed from June to November 2021. Exposure: Venlafaxine extended release (dose ranging from 37.5 mg to 300 mg daily) for up to 12 weeks. Main Outcomes and Measures: The association between a composite biomarker-based index (SASP index) and treatment remission in older adults with major depression was measured using clinical data and blood samples. Results: There were 416 participants with a mean (SD) age of 60.02 (7.13) years; 64% (265 participants) were self-reported female, and the mean (SD) Montgomery-Asberg Depression Rating Scale score was 26.6 (5.7). Higher SASP index scores were independently associated with higher rates of nonremission, with an increase of 1 unit in the SASP index score increasing the odds of nonremission by 19% (adjusted odds ratio, 1.19; 95% CI, 1.05-1.35; P =.006). In contrast, no individual SASP factors were associated with remission in LLD. Conclusions and Relevance: Using clinical data and blood samples from a nonrandomized clinical trial, the results of this study suggest that molecular and cellular senescence, as measured with the SASP index, is associated with worse treatment outcomes in LLD. Combining this index score reflecting interrelated biological processes with other molecular, clinical, and neuroimaging markers may be useful in evaluating antidepressant treatment outcomes. These findings inform a path forward for geroscience-guided interventions targeting senescence to improve remission rates in LLD. Trial Registration: ClinicalTrials.gov Identifier: NCT00892047. © 2022 American Medical Association. All rights reserved.Open access journalThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]